Updated 06:09 GMT, 18 Nov 2026 SPX 7,340.53 -1.03% NDX 27,001.78 -0.72% VIX 25.46 +11.13% GOLD 3,790.40 -1.91% CL 84.69 -1.53% BTC 64,606.17 -0.38%
NAS100 27,002 −0.72% S&P 7,341 −1.03% GOLD $3,790 −1.91% BTC $64,606 −0.38% VIX 25.46 +11.13% latest tape · as of 06:09 UTC
The Screen · Financials · Credit Services

CPI Card Group Inc

PMTS · NASDAQ · USD · Market cap $219M · 1,700 employees

CPI Card Group Inc., together with its subsidiaries, provides physical and digital payment solutions for financial institutions, processors, fintechs, prepaid program managers, and other organizations in the United States.

FAIL · Does not pass the screen
25.86 USD

Price as of 17 Nov 2026Daily close, not a live quote

Screened 2026-11-17 · the tape above runs as of 06:09 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price25.86 USD at the 17 Nov 2026 close
  • Our value readUndervalued vs our fair value, as of 17 Nov 2026
  • Our regime readMarkup, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed17 Nov 2026 (1 day ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: $30.00 to $49.86, base estimate $30.00 (screen dated 2026-11-17).

Current read
Markup ?
Undervalued · screened 2026-11-17
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price25.86 USD
Fair value30.00
Ethical score30.0/100
Value readUndervaluedas of 17 Nov 2026
Our investment reviews on this name
2026-11-12Read Distribution25.34+2.1% to today Markdown gives way to Distribution after a 10% slide in 7 days
2026-11-05Read Markdown28.24-8.4% to today ✓Accumulation gives way to Markdown after an 11% rise in 3 weeks
2026-10-15Read Accumulation25.54+1.3% to today ✓Distribution gives way to Accumulation after a 6% rise in 13 days
2026-10-02Read Distribution24.14+7.1% to today Markup gives way to Distribution after a 27% rise in 13 weeks

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

CPI Card Group Inc holds its Markup at $25.86. Consolidating, no directional conviction, held for 1 days.

As held on the ledger · 2026-11-17
PhaseMarkup
Quantitative stateConsolidating, no directional conviction, held for 1 days
Price at the screen$25.86
Valuation23.67 trailing · 7.11 forward price to earnings
Values screenFAIL · score 30.0
Beta1.06
The Workings

Five Screens, Shown in Full

Does not pass. Excluded industry: Credit Services

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Excluded industry: Credit Services Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

CPI Card does not clear the screen at the business-activity stage. It operates in an area the screen excludes: Credit Services, so the financial ratios are not the deciding factor here.

Read as at 2026-11-17. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when PMTS's ethical verdict changes

Today PMTS does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

What the Numbers Say It Is Worth

The Fair Value Range

Our analysis reads Undervalued vs our fair value, as of 17 Nov 2026: it trades at roughly a 14% discount to our $30.00 fair value, none competitive moat, 19.80% revenue growth.

How a fair value is estimated: discounted cash flow (DCF).

30.00Conservative30.00Base case49.86Growth case 25.86Price

Fair value range in USD, drawn from the 2026-11-17 screen. The gold marker is the market price at the same screen. A 13.8% discount to the base estimate.

The Street's Range
25.00Street low 27.50Street average 30.00Street high 25.86Price

Third-party analyst targets. The average target sits +6% from the screen price.

Reading the gap · Both our model and the analysts see meaningful upside from here.

Price History & Projections

Where our models see it going: fair-value estimate $30.00, with a range of $30.00 to $49.86, dated to the 2026-11-17 screen.

Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.

The Business, in Plain Words

Why it stands out

A 20%-growth business trading at just 7.1x forward earnings, with a none competitive moat. That is a 14% discount to our $30.00 fair value: the market is pricing it cautiously while the fundamentals argue otherwise.

The fundamentals · plain-English read
Forward P/E7.1xcheap for a company growing this fast
Trailing P/E23.7xa premium valuation
EPS, trailing1.02
EPS, forward3.40
Revenue growth+19.8%steady growth
Profit margin2.2%barely profitable
Beta1.06moves a little more than the market
52-week range10.81 - 25.50
MoatNONE
Market cap$219M
Employees1,700

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

Where & How to Trade

PMTS trades on NASDAQ. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-12 Distribution · changed $25.34 -10.3% Entry 10

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 10.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 27% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28. Insiders have been net buyers over the past quarter. Since the last review it its composite score rose.

2026-11-05 Markdown · changed $28.24 +7.5% Entry 9

The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 7.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 49% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28. Insiders have been net buyers over the past quarter. Since the last review it its composite score rose.

2026-10-29 Accumulation $26.26 +2.8% Entry 8

The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 49% above its long-term trend line with momentum reading overbought. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28. Insiders have been net buyers over the past quarter.

2026-10-15 Accumulation · changed $25.54 +5.8% Entry 7

The framework has shifted from distribution to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is momentum reading bullish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28. Insiders have been net buyers over the past quarter.

2026-10-02 Distribution · changed $24.14 +26.7% Entry 6

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 26.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bullish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28. Insiders have been net buyers over the past quarter. Since the last review it its composite score eased.

2026-09-09 Markup $19.05 +0.0% Entry 5

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bullish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28.

2026-08-08 Markup $19.05 +0.0% Entry 4

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bullish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28.

2026-07-18 Markup $19.05 +0.0% Entry 3

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is momentum reading bullish. Over the past year the shares are down 16%. Our forward projection puts the odds of a 10% gain over the next month near 27%. The street (4 analysts) rates it none, with a mean price target of $28.

2026-07-03 Markup $19.05 +0.0% Entry 2

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Markup $19.05 Entry 1

Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · PMTS
DateInsiderTitleTypeSharesValue
2026-09-14 Parallel49 Equity, Ulc 10% S - Sale 2,687,921 $54,900,786
2026-09-14 Tricor Pmt25 Holdings Inc. 10% P - Purchase 525,000 $11,287,500
2026-09-14 Riley H Sanford Non-Executive Chairman P - Purchase 13,953 $299,990
2026-09-14 Mallela Ravi Dir P - Purchase 1,000 $21,500
2026-09-14 Peters Nicholas Dir P - Purchase 11,628 $250,002
2026-09-14 Sheinbaum Marc Dir P - Purchase 4,651 $99,997

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $15.29 +20.8% · $1,208 +20.8%
2 months $17.43 +6.0% · $1,060 +6.0%
3 months $15.47 +19.4% · $1,194 +19.4%
6 months $17.99 +2.7% · $1,027 +2.7%
1 year $21.93 -15.8% · $842 -15.8%
2 years $27.13 -31.9% · $681 -31.9%
3 years $23.03 -19.8% · $802 -19.8%
5 years $19.00 -2.8% · $972 -2.8%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever PMTS does next, these words stay.

CPI Card Group Inc · PMTS · Markup · $25.86
Recorded 2026-11-17 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.